Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

101.91
Delayed Data
As of Sep 03
 -2.36 / -2.26%
Today’s Change
85.95
Today|||52-Week Range
123.37
+8.12%
Year-to-Date

Today’s Trading

Previous close104.27
Today’s open104.92
Day’s range101.69 - 105.00
Volume9,928,124
Average volume (3 months)10,894,138
Market cap$153.0B
Dividend yield1.69%
Data as of 4:14pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+42.86%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+121.81%
P/E ratio10.8
Price/Sales6.24
Price/Book10.13

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-3.06-2.01%
BIIBBiogen-2.58-0.85%
BXLTBaxalta Inc+1.11+3.17%
BAXBaxter International...-0.35-0.94%
Data as of 4:04pm ET, 09/03/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)$2.82
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

Partner Offers